Stay updated on Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial page.

Latest updates to the Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial page
- ChecktodayChange DetectedRevision updated from v3.5.3 to v3.5.4 on the page, indicating a platform release or update to the study record interface.SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page metadata indicates an update to the ClinicalTrials.gov site revision (from v3.5.2 to v3.5.3), with no changes to the underlying study information shown.SummaryDifference0.0%

- Check29 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check43 days agoChange DetectedThe Italy location listing was updated from Padua, Italy, 35128 to Padova, Italy, 35128.SummaryDifference0.0%

- Check58 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3, replacing the previous version. This likely reflects a behind-the-scenes maintenance update.SummaryDifference0.0%

Stay in the know with updates to Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial page.